In an effort to provide you with timely market feedback from ASCO 2012, OBR and MDOutlook Oncology Intelligence are pleased to share results from MDOutlook’s 5th Annual post-ASCO survey fielded among its global network of more than 62,000 cancer providers.
This second Quick-Poll to be published in the OBR blog explores Non-Small Cell Lung Cancer (NSCLC) & Renal Cell Carcinoma (RCC), and stay tuned to our blog in the coming weeks as we publish QuickPolls on the other tumor types as well.
Quick polls are a fast way of measuring expected acceptance of clinical data post major medical meetings, and perhaps can be used to make some assumptions about adoption amongst providers. In today’s information hungry environment, the speed at which these polls can be conducted and analyzed can be advantageous for market planning and “pressure testing” acceptance of data amongst key stakeholders.
You must be logged in to post a comment